Prostate cancer detection with 3 T MRI: Comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

✍ Scribed by Kazuhiro Kitajima; Yasushi Kaji; Yoshitatsu Fukabori; Ken-ichiro Yoshida; Narufumi Suganuma; Kazuro Sugimura

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 198 KB
• Volume: 31
• Category: Article
• ISSN: 1053-1807
• DOI: 10.1002/jmri.22075

✦ Synopsis

Abstract

Purpose:

To evaluate the diagnostic ability of diffusion‐weighted imaging (DWI) and dynamic contrast‐enhanced imaging (DCEI) in combination with T2‐weighted imaging (T2WI) for the detection of prostate cancer using 3 T magnetic resonance imaging (MRI) with a phased‐array body coil.

Materials and Methods:

Fifty‐three patients with elevated serum levels of prostate‐specific antigen (PSA) were evaluated by T2WI, DWI, and DCEI prior to needle biopsy. The obtained data from T2WI alone (protocol A), a combination of T2WI and DWI (protocol B), a combination T2WI and DCEI (protocol C), and a combination of T2WI plus DWI and DCEI (protocol D) were subjected to receiver operating characteristic (ROC) curve analysis.

Results:

The sensitivity, specificity, accuracy, and area under the ROC curve (Az) for region‐based analysis were: 61%, 91%, 84%, and 0.8415, respectively, in protocol A; 76%, 94%, 90%, and 0.8931, respectively, in protocol B; 77%, 93%, 89%, and 0.8655, respectively, in protocol C; and 81%, 96%, 92%, and 0.8968, respectively in protocol D. ROC analysis revealed significant differences between protocols A and B (P = 0.0008) and between protocols A and D (P = 0.0004).

Conclusion:

In patients with elevated PSA levels the combination of T2WI, DWI, DCEI using 3 T MRI may be a reasonable approach for the detection of prostate cancer. J. Magn. Reson. Imaging 2010;31:625–631. © 2010 Wiley‐Liss, Inc.